Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003)

Madhav V. Dhodapkar, Joth L. Jacobson, Morie A. Gertz, Saul E. Rivkin, G. David Roodman, Joseph M. Tuscano, Muhammad Shurafa, Robert A. Kyle, John J. Crowley, Bart Barlogie

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Fingerprint Dive into the research topics of 'Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003)'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences